CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242

Abstract

CA125 represents a significant and independent prognostic factor in CRC patients, superior to CEA. Furthermore, CA242 served as a better prognostic marker than both CEA and CA19-9. We recommend including both CA125 and CA242 in prognostic clinical trials among CRC patients.